tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
US Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports
Want to see GSK full AI Analyst Report?

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

5,254 Followers

GlaxoSmithKline (GSK) Ownership Overview

6.17%7.96%0.35%85.52%
6.17% Mutual Funds
7.96% Other Institutional Investors
0.35% ETFs
85.52% Public Companies and
Individual Investors
The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 14.48% of the company’s stock is owned by Institutional Investors, and 85.52% is owned by Public Companies and Individual Investors.
The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 8.31% of the company’s stock is owned by Institutional Investors, 6.17% is owned by Insiders, and 85.52% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2026
Brandes Investment Partners Lp
xxxxxxxxxxxxx
$77749239
Jun 30, 2026
Tweedy Browne Co Llc
xxxxxxxxxxxxx
$4273645
Jun 30, 2026
Causeway Capital Management Llc
xxxxxxxxxxxxx
$375484
Jun 30, 2026
Bridgewater Associates, Lp
xxxxxxxxxxxxx
$26428644
Show More Hedge Fund Trading Activity >

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
John A. Gunn
48,197,514Institution2.38%2,319,746,349
47,215,672Institution2.33%2,272,490,293
Ken Fisher
35,722,792Institution1.77%1,719,337,979
Theofanis Kolokotrones
25,182,068Institution1.24%1,212,012,933
18,147,650Institution0.90%873,446,395
9,185,065Institution0.45%442,077,178
7,943,164Institution0.39%382,304,483
5,537,594Institution0.27%266,524,399
4,089,400Institution0.20%196,822,822
3,544,080Institution0.18%170,576,570

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
47,215,672Institution2.33%2,272,490,293
18,147,650Institution0.90%873,446,395
9,185,065Institution0.45%442,077,178
7,943,164Institution0.39%382,304,483
5,537,594Institution0.27%266,524,399
4,089,400Institution0.20%196,822,822
3,544,080Institution0.18%170,576,570
3,442,475Institution0.17%165,686,322
2,948,967Institution0.15%141,933,782
2,734,200Institution0.14%131,597,046

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
Avantis
1,416,001Institution0.07%68,137,968
Fidelity
1,150,939Institution0.06%55,383,185
VanEck
838,149Institution0.04%40,331,730
First Trust
660,571Institution0.03%31,793,282
GMO
314,596Institution0.02%15,138,360
Hartford
298,913Institution0.01%14,383,694
Evolve
230,074Institution0.01%15,316,398
Evolve
230,074Institution0.01%15,316,398
Avantis
212,008Institution0.01%10,201,825
Brandes
185,569Institution<0.01%8,931,436

FAQ

Who Owns GlaxoSmithKline (GSK)?
Currently, no data Available
What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.96% of GlaxoSmithKline (GSK) stock is held by institutional investors.
    What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?
    According to the latest TipRanks data, approximately 85.52% of GlaxoSmithKline (GSK) stock is held by retail investors.
      Who owns the most shares of GlaxoSmithKline (GSK)?
      John A. Gunn owns the most shares of GlaxoSmithKline (GSK).
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.